Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Multiple Endocrine Neoplasia Type 1: Latest Insights.Endocr Rev. 2021; 42: 133-170
- MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.BMC Med. 2016; 14: 182
- Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis.Front Endocrinol (Lausanne). 2019; 10: 339
- Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.Endocrine. 2018; 62 (published correction appears in Endocrine. 2018 Jul 21): 215-233
- Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.F1000Res. 2017; 6 (Faculty Rev-73. Published 2017 Jan 24): F1000
- Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype–phenotype Correlations.Front Endocrinol (Lausanne). 2020; 11: 591501
- Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).J Clin Endocrinol Metab. 2012; 97: 2990-3011
- MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group.J Clin Endocrinol Metab. 2017; 102: 2083-2090
- Clinical aspects of multiple endocrine neoplasia type 1.Nat Rev Endocrinol. 2021; 17: 207-224
- Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.Endocrine. 2017; 58: 349-359
- The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis.J Endocrinol Invest. 2008; 31: 905-909
- Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.Int J Mol Sci. 2020; 21: 7592
- Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype–phenotype correlation.Clinics (Sao Paulo). 2012; 67: 49-56
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.Hum Mutat. 2008; 29: 22-32
- Neuroendocrine tumours: cracking the epigenetic code.Endocr Relat Cancer. 2013; 20: R65-R82
- The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.Endocr Relat Cancer. 2019; 26: R519-R544
- Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.Int J Mol Sci. 2021; 22: 4041
- Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.J Mol Endocrinol. 2018; 61: R13-R24
- Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.Ann Surg. 2008; 247: 501-510
- Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.J Clin Endocrinol Metab. 2004; 89: 3776-3784
- The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.Endocrinol Metab Clin North Am. 2018; 47: 463-470
- Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens.Neuroendocrinology. 2019; 109: 165-170
- The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.Pancreas. 2020; 49: 1-33
- A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–phenotype Correlations.Front Endocrinol (Lausanne). 2021; 12: 681013
- Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.Pancreas. 2017; 46: 589-594
- Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.Neuroendocrinology. 2021; 111: 609-630
- Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.Endocr Relat Cancer. 2020; 27: R145-R161
- Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?.Surgery. 2000; 128: 958-966
- Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.Orphanet J Rare Dis. 2018; 13: 205
- True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.Endocrine. 2019; 65: 451-459
- Genotype–phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution.Surgery. 2018; 163: 212-217
- Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.J Clin Endocrinol Metab. 2014; 99: E2387-E2391
- Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.Hum Mol Genet. 2013; 22: 1940-1948
- Genetic and epigenetic alterations in pancreatic neuroendocrine tumors.J Gastrointest Oncol. 2020; 11: 567-577
- DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.Eur J Endocrinol. 2018; 179: 153-160
- Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.J Clin Endocrinol Metab. 2020; 105: 3285-3294
- Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.Cancer. 2019; 125: 1247-1257
- Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.Cancer Biol Ther. 2016; 17: 1274-1281
- Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1.Proc Natl Acad Sci U S A. 2011; 108: 13379-13386
- Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.Mol Cancer Res. 2015; 13: 689-698
Article info
Identification
Copyright
Published by Elsevier Inc.
